glp-1 ncbi Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext GLP-1 physiology in obesity and

Risk of dementia in diabetes mellitus: a systematic review

Improves Blood Sugar Control This prevents sugar spikes and excessive hunger

revenue dipped 8% to $530 million in Q1, while international revenue jumped nearly tenfold to $78 million in the quarter

Reflecting on the clinical implications, St-Pierre says that the findings support cautious use of GLP-1 RAs in selected patients with IBD when prescribed for approved metabolic indications, with appropriate counselling and monitoring. At the same time, she noted that the findings highlight substantial evidence gaps and believes future research should move beyond proxy outcomes and incorporate prospective, IBD-specific designs that integrate objective inflammatory measures with robust metabolic phenotyping. Moreover, there should be special considerations on the effects of GLP-1 RAs on body composition of patients with IBD, she adds